[go: up one dir, main page]

WO2006054262A3 - Use of phage display technique for identifying peptides capable of binding progenitor/stem cells, peptides thereby obtained and uses thereof - Google Patents

Use of phage display technique for identifying peptides capable of binding progenitor/stem cells, peptides thereby obtained and uses thereof Download PDF

Info

Publication number
WO2006054262A3
WO2006054262A3 PCT/IB2005/053811 IB2005053811W WO2006054262A3 WO 2006054262 A3 WO2006054262 A3 WO 2006054262A3 IB 2005053811 W IB2005053811 W IB 2005053811W WO 2006054262 A3 WO2006054262 A3 WO 2006054262A3
Authority
WO
WIPO (PCT)
Prior art keywords
peptides
stem cells
phage display
display technique
progenitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2005/053811
Other languages
French (fr)
Other versions
WO2006054262A2 (en
Inventor
Roberto Perris
Nardo Paolo Di
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universita degli Studi di Roma Tor Vergata
Universita degli Studi di Roma La Sapienza
Original Assignee
Universita degli Studi di Roma Tor Vergata
Universita degli Studi di Roma La Sapienza
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universita degli Studi di Roma Tor Vergata, Universita degli Studi di Roma La Sapienza filed Critical Universita degli Studi di Roma Tor Vergata
Publication of WO2006054262A2 publication Critical patent/WO2006054262A2/en
Publication of WO2006054262A3 publication Critical patent/WO2006054262A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/02—Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The present application relates to the utilization of phage display technique, based on phage libraries of random sequence type or with defined amino acid sequences for identifying peptide sequences capable of binding human progenitor/stem cells, as well as peptides and derivatives thereof identified and isolated by such methods. The present invention further relates to methods of recognizing, monitoring and modifying progenitor/stem cells by use of complexes comprising said peptides and derivatives .
PCT/IB2005/053811 2004-11-18 2005-11-18 Use of phage display technique for identifying peptides capable of binding progenitor/stem cells, peptides thereby obtained and uses thereof Ceased WO2006054262A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITRM2004A000568 2004-11-18
ITRM20040568 ITRM20040568A1 (en) 2004-11-18 2004-11-18 USE OF THE "PHAGE DISPLAY" TECHNIQUE FOR THE IDENTIFICATION OF PEPTIDES WITH CAPACITY OF STAMIN CELLS / PROGENITOR, PEPTIDES SO OBTAINED AND THEIR USES.

Publications (2)

Publication Number Publication Date
WO2006054262A2 WO2006054262A2 (en) 2006-05-26
WO2006054262A3 true WO2006054262A3 (en) 2006-10-05

Family

ID=36407529

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2005/053811 Ceased WO2006054262A2 (en) 2004-11-18 2005-11-18 Use of phage display technique for identifying peptides capable of binding progenitor/stem cells, peptides thereby obtained and uses thereof

Country Status (2)

Country Link
IT (1) ITRM20040568A1 (en)
WO (1) WO2006054262A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9528109B2 (en) 2007-10-26 2016-12-27 Biomarin Technologies B.V. Methods and means for efficient skipping of exon 45 in duchenne muscular dystrophy pre-mRNA

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2049664T1 (en) 2006-08-11 2012-04-30 Prosensa Technologies Bv Single stranded oligonucleotides complementary to repetitive elements for treating DNA repeat instability associated genetic disorders
US8501905B2 (en) 2007-03-22 2013-08-06 The Regents Of The University Of California Synthetic cell platforms and methods of use thereof
EP1985708B1 (en) * 2007-04-27 2015-04-15 Universität Rostock Selective targeting of viruses to neural precursor cells
EP2167136B1 (en) 2007-07-12 2016-04-20 BioMarin Technologies B.V. Molecules for targeting compounds to various selected organs or tissues
CN101790385A (en) 2007-07-12 2010-07-28 普罗森那技术公司 Molecules for targeting compounds to various selected organs, tissues or tumor cells
USRE48468E1 (en) 2007-10-26 2021-03-16 Biomarin Technologies B.V. Means and methods for counteracting muscle disorders
JP2011510678A (en) 2008-02-08 2011-04-07 プロセンサ ホールディング ビーブイ Methods and means for treating DNA repeat instability related genetic disorders
EP2119783A1 (en) 2008-05-14 2009-11-18 Prosensa Technologies B.V. Method for efficient exon (44) skipping in Duchenne Muscular Dystrophy and associated means
US20110003702A1 (en) * 2009-06-03 2011-01-06 President And Fellows Of Harvard College Methods, systems, and kits for identification of osteoinductive peptides
NZ595955A (en) 2009-04-24 2012-10-26 Prosensa Technologies Bv Oligonucleotide comprising an inosine for treating dmd
US9334306B2 (en) * 2011-07-09 2016-05-10 The Regents Of The University Of California Leukemia stem cell targeting ligands and methods of use
CN112251436A (en) 2012-01-27 2021-01-22 比奥马林技术公司 RNA-regulated oligonucleotides with improved properties for the treatment of duchenne muscular dystrophy and becker muscular dystrophy
US9175263B2 (en) * 2012-08-22 2015-11-03 Biotime, Inc. Methods and compositions for targeting progenitor cell lines
EP3003290B1 (en) 2013-06-05 2021-03-10 AgeX Therapeutics, Inc. Compositions for use in the treatment of wounds in mammalian species
CN103497236B (en) * 2013-09-25 2017-05-10 浙江省医学科学院 Specific heptapeptide targeting to WISP-1 protein and application thereof
US10240127B2 (en) 2014-07-03 2019-03-26 ReCyte Therapeutics, Inc. Exosomes from clonal progenitor cells
EP3387112A4 (en) 2015-12-07 2019-08-21 BioTime, Inc. METHODS FOR RETRANSTIGATION OF VARIOUS CELLS OF ADIPOSE BROWN TISSUE DERIVED FROM PLURIPOTENT STEM CELLS

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002020822A2 (en) * 2000-09-08 2002-03-14 Board Of Regents, The University Of Texas System Biopanning and rapid analysis of selective interactive ligands (brasil)
US20030219826A1 (en) * 1999-09-01 2003-11-27 Robbins Paul D. Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, DNA and viruses

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030219826A1 (en) * 1999-09-01 2003-11-27 Robbins Paul D. Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, DNA and viruses
WO2002020822A2 (en) * 2000-09-08 2002-03-14 Board Of Regents, The University Of Texas System Biopanning and rapid analysis of selective interactive ligands (brasil)

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BARRY ET AL: "Towards cell-targeting gene therapy vectors: selection of cell-binding peptids from random peptide-presenting phage libraries", NATURE MEDICINE, NATURE PUBLISHING GROUP, NEW YORK, NY, US, vol. 2, no. 3, March 1996 (1996-03-01), pages 299 - 305, XP002086381, ISSN: 1078-8956 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9528109B2 (en) 2007-10-26 2016-12-27 Biomarin Technologies B.V. Methods and means for efficient skipping of exon 45 in duchenne muscular dystrophy pre-mRNA

Also Published As

Publication number Publication date
WO2006054262A2 (en) 2006-05-26
ITRM20040568A1 (en) 2005-02-18

Similar Documents

Publication Publication Date Title
WO2006054262A3 (en) Use of phage display technique for identifying peptides capable of binding progenitor/stem cells, peptides thereby obtained and uses thereof
WO2007149062A3 (en) Bioactive fus1 peptides and nanoprticle-polypeptide complexes
WO2010011313A3 (en) Ligation of stapled polypeptides
EP4374913A3 (en) Novel human serum albumin mutant
EP4269562A3 (en) Antigen binding molecules and methods of use thereof
WO2008113536A8 (en) Neurotrophic peptides
NZ601647A (en) Variant hhip1 protein and methods and uses thereof
WO2007039231A3 (en) Method of producing a modified (poly)peptide
WO2006135793A3 (en) Protein engineering with analogous contact environments
WO2008142664A3 (en) Exposed thymidine kinase 1 peptides, ligands and methods employing the same
WO2007029262A3 (en) Compositions and methods using same for the detection of viruses
EP2811030A3 (en) Improved beta Thymosin fragments
WO2006086607A3 (en) Novel proteins with enhanced functionality and methods of making novel proteins using circular permutation
WO2005000870A3 (en) Isolated ny-eso-1 peptides which bind to hla class ii molecules and uses thereof
WO2012015979A3 (en) Hmgb1-derived peptides enhance immune response to antigens
WO2003054009A3 (en) Apoptotically active peptides
WO2002040683A3 (en) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
EP1842911A4 (en) HLA-BINDING PEPTIDES, DNA FRAGMENTS ENCODING SUCH PEPTIDES AND RECOMBINANT VECTORS
WO2005072766A3 (en) Peptides that bind to hsp90 proteins
WO2007075845A3 (en) Isolated mcpip and methods of use
NZ605799A (en) Wdrpuh epitope peptides and vaccines containing the same
WO2004000870A3 (en) Two synthetic peptides for treatment and prevention of cancers
WO2007066018A3 (en) Novel peptides and the biological use thereof
WO2004078776A3 (en) Ny-eso-1 peptides which bind to class ii molecules and uses thereof
WO2005107364A3 (en) Polynucleotide, polypeptides, and diagnostic methods

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KN KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 05812026

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 05812026

Country of ref document: EP

Kind code of ref document: A2